突变衍生新抗原和非经典抗原对抗癌疗法的相关性
Belen Aparicio1,2,3,4, Patrick Theunissen2,3,4,5, Sandra Hervas-Stubbs1,2,3,4
1Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA) University of Navarra, Pamplona, Spain.
癌症免疫疗法依赖于识别瘤抗原. 新方法揭示了新抗原 (neoAgs) 和非经典抗原,改善了癌症治疗策略和向能力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 癌症免疫疗法的有效性取决于淋巴细胞识别瘤抗原.
- 抗原鉴定对于理解免疫疗法反应和开发更好的策略至关重要.
- 下一代测序可以从突变中识别新抗原 (neoAgs),推动新的治疗方法.
研究的目的:
- 审查新抗原在癌症免疫疗法中的作用.
- 讨论基于新抗原的疗法的策略和结果.
- 描述非经典的瘤抗原及其识别方法.
主要方法:
- 关于瘤抗原和免疫疗法的现有文献的审查.
- 对新抗原发现的下一代测序应用的分析.
- 描述识别非经典瘤抗原的方法.
主要成果:
- 新抗原在各种免疫疗法中越来越重要.
- 基于新抗原的策略在癌症治疗中显示出有希望的结果.
- 新的方法正在扩大可识别的瘤抗原的范围.
结论:
- 了解新抗原和非经典瘤抗原是推动癌症免疫疗法的关键.
- 改进的抗原识别扩大了可向分子的范围,以实现更有效的癌症治疗.
更多相关视频
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
相关概念视频
Mitogens and the Cell Cycle
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mutagenicity and Carcinogenicity
